Review



nbd-ps (16:0–12:0  (Avanti Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Avanti Inc nbd-ps (16:0–12:0

    Nbd Ps (16:0–12:0, supplied by Avanti Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nbd-ps (16:0–12:0/product/Avanti Inc
    Average 90 stars, based on 1 article reviews
    nbd-ps (16:0–12:0 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "PDZD8-deficient mice accumulate cholesteryl esters in the brain as a result of impaired lipophagy"

    Article Title: PDZD8-deficient mice accumulate cholesteryl esters in the brain as a result of impaired lipophagy

    Journal: iScience

    doi: 10.1016/j.isci.2022.105612


    Figure Legend Snippet:

    Techniques Used: Produced, Recombinant, Modification, Transfection, Mutagenesis, Software, Microscopy, Blocking Assay, Real-time Polymerase Chain Reaction



    Similar Products

    nbd ps  (Avanti Polar)
    94
    Avanti Polar nbd ps
    PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in <xref ref-type=Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 . " width="250" height="auto" />
    Nbd Ps, supplied by Avanti Polar, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nbd ps/product/Avanti Polar
    Average 94 stars, based on 1 article reviews
    nbd ps - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    nbd ps  (Croda International Plc)
    94
    Croda International Plc nbd ps
    PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in <xref ref-type=Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 . " width="250" height="auto" />
    Nbd Ps, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nbd ps/product/Croda International Plc
    Average 94 stars, based on 1 article reviews
    nbd ps - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    lipids catalog number 810193 3  (Croda International Plc)
    94
    Croda International Plc lipids catalog number 810193 3
    PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in <xref ref-type=Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 . " width="250" height="auto" />
    Lipids Catalog Number 810193 3, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lipids catalog number 810193 3/product/Croda International Plc
    Average 94 stars, based on 1 article reviews
    lipids catalog number 810193 3 - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    palmitoyl  (Croda International Plc)
    94
    Croda International Plc palmitoyl
    PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in <xref ref-type=Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 . " width="250" height="auto" />
    Palmitoyl, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/palmitoyl/product/Croda International Plc
    Average 94 stars, based on 1 article reviews
    palmitoyl - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    nbd-ps (16:0–12:0), 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoserine (ammonium salt  (Croda International Plc)
    90
    Croda International Plc nbd-ps (16:0–12:0), 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoserine (ammonium salt
    PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in <xref ref-type=Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 . " width="250" height="auto" />
    Nbd Ps (16:0–12:0), 1 Palmitoyl 2 {12 [(7 Nitro 2 1,3 Benzoxadiazol 4 Yl)Amino]Dodecanoyl} Sn Glycero 3 Phosphoserine (Ammonium Salt, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nbd-ps (16:0–12:0), 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoserine (ammonium salt/product/Croda International Plc
    Average 90 stars, based on 1 article reviews
    nbd-ps (16:0–12:0), 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}-sn-glycero-3-phosphoserine (ammonium salt - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cat 810193c nbd pa  (Croda International Plc)
    94
    Croda International Plc cat 810193c nbd pa
    PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in <xref ref-type=Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 . " width="250" height="auto" />
    Cat 810193c Nbd Pa, supplied by Croda International Plc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cat 810193c nbd pa/product/Croda International Plc
    Average 94 stars, based on 1 article reviews
    cat 810193c nbd pa - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    nbd-ps (16:0–12:0  (Avanti Inc)
    90
    Avanti Inc nbd-ps (16:0–12:0

    Nbd Ps (16:0–12:0, supplied by Avanti Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nbd-ps (16:0–12:0/product/Avanti Inc
    Average 90 stars, based on 1 article reviews
    nbd-ps (16:0–12:0 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in <xref ref-type=Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 . " width="100%" height="100%">

    Journal: iScience

    Article Title: PDZD8-deficient mice accumulate cholesteryl esters in the brain as a result of impaired lipophagy

    doi: 10.1016/j.isci.2022.105612

    Figure Lengend Snippet: PDZD8 possesses PS and cholesterol transfer activity (A and B) Phospholipid transfer activity of His 6 -PDZD8(ΔTM) in the absence (A) or presence (B) of acceptor liposomes as determined with the liposome-FRET assay shown in Figure S4 A. The amount of transferred lipid (nM) is shown. (C) PS transfer activity of His 6 -PDZD8 deletion mutants in the presence of acceptor liposomes. (D) Domain structure of mouse wild-type PDZD8 [PDZD8(WT)] and its deletion mutants. A summary of the PS and cholesterol transfer activities of each mutant determined as in (C) and (H), respectively, is shown on the right. ND, not determined. (E) Schematic representation of model for the accessibility of cholesterol to PDZD8-SMP in PS-poor (left) or PS-rich (right) domains of a lipid bilayer. (F) Schematic representation of the liposome-FRET assay for cholesterol transfer by His 6 -PDZD8(ΔTM) as performed with donor liposomes containing rhodamine-PE, NBD-cholesterol, and DGS-NTA(Ni) and in the absence or presence of acceptor liposomes. The lipid constituents of the liposomes are shown in the boxes later in discussion. (G) Cholesterol transfer activity of PDZD8(ΔTM) in the absence or presence of acceptor liposomes. (H) Cholesterol transfer activity of the indicated PDZD8 deletion mutants in the presence of acceptor liposomes. (I) Model for the mechanism of lipid transfer by PDZD8, indicating that PDZD8 exchanges PS and cholesterol between the ER and Rab7-positive organelles in a manner dependent on its SMP domain. See also Figure S4 .

    Article Snippet: All lipids were obtained from Avanti Polar Lipids: POPC (16:0–18:1), 1-palmitoyl-2-oleoyl- sn -glycero-3-phosphocholine; POPE (16:0–18:1), 1-palmitoyl-2-oleoyl- sn -glycero-3-phosphoethanolamine; POPS (16:0–18:1), 1-palmitoyl-2-oleoyl- sn -glycero-3-phospho-L-serine; rhodamine-DPPE (18:1 Liss Rhod-PE), 1,2-dioleoyl- sn -glycero-3-phosphoethanolamine- N -(lissamine rhodamine B sulfonyl); NBD-PS (16:0–12:0), 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}- sn -glycero-3-phosphoserine (ammonium salt); NBD-PE (18:1–12:0), 1-oleoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}- sn -glycero-3-phosphoethanolamine; NBD-PC (16:0–12:0), 1-oleoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}- sn -glycero-3-phosphocholine; NBD-PA (16:0–12:0), 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl}- sn -glycero-3-phosphate (ammonium salt); and 25-NBD-cholesterol, 25-{ N -[(7-nitro-2-1,3-benzoxadiazol-4-yl)methyl]amino}-27-norcholesterol.

    Techniques: Activity Assay, Mutagenesis

    Journal: iScience

    Article Title: PDZD8-deficient mice accumulate cholesteryl esters in the brain as a result of impaired lipophagy

    doi: 10.1016/j.isci.2022.105612

    Figure Lengend Snippet:

    Article Snippet: NBD-PS (16:0–12:0) , Avanti , Cat#810193C.

    Techniques: Produced, Recombinant, Modification, Transfection, Mutagenesis, Software, Microscopy, Blocking Assay, Real-time Polymerase Chain Reaction